TCAIM-Mediated Regulation of OGDH and Mitochondrial Metaboli
2026-05-31
This study uncovers a novel post-translational regulatory mechanism by which the mitochondrial DNAJC co-chaperone TCAIM selectively reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, thereby modulating TCA cycle activity and cellular metabolism. The findings highlight a previously unappreciated function for mitochondrial co-chaperones in metabolic control, with implications for disease modeling and metabolic research.
Indomethacin: A Molecular Probe for Adipocyte Differentiatio
2026-05-30
Explore how Indomethacin, a nonsteroidal anti-inflammatory drug, enables advanced research into adipocyte differentiation and non-shivering thermogenesis. This article uniquely bridges mechanistic pharmacology and metabolic assay design, providing actionable insights for inflammation and lipid metabolism studies.
Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cytosk
2026-05-29
Y-27632 dihydrochloride is a potent, selective ROCK inhibitor widely used to study cytoskeletal organization, cell proliferation, and stem cell viability. Its high affinity for ROCK1 and ROCK2, combined with robust selectivity, makes it a gold standard in cancer and regenerative research. This article details its molecular action, evidence base, and best practices for experimental use.
Protein A/G Magnetic Beads: Enabling Precision in Vascular P
2026-05-29
Discover how Protein A/G Magnetic Beads streamline antibody purification and protein interaction studies, with a focus on vascular research. This article uniquely integrates advanced immunoprecipitation workflows with cutting-edge cardiovascular epigenetics.
Honokiol in Immunometabolism: Beyond NF-κB Pathway Inhibitio
2026-05-28
Explore Honokiol as a research-grade small molecule in immunometabolic and tumor microenvironment studies. This article uniquely connects Honokiol’s mechanisms to contemporary T cell metabolic research, offering advanced insight for assay design.
RITA (NSC 652287): Applied Cancer Research Workflows & Tips
2026-05-28
RITA (NSC 652287) empowers precise modulation of the p53 pathway, enabling reliable cytotoxicity profiling and tumor regression studies in cancer biology. This guide translates advanced literature and protocol innovations into actionable steps for apoptosis assays, xenograft models, and renal carcinoma research.
Transcriptional 'Timebomb' Defense in Catharanthus roseus
2026-05-27
This study reveals how Catharanthus roseus deploys a unique compartmentalized chemical defense, activating toxic alkaloid dimers only upon herbivory. The research uncovers a transcription factor (HIVE) that orchestrates metabolic resource allocation between herbivore defense and cold tolerance, providing insight into plant adaptation strategies.
MDV3100 (Enzalutamide): Precision Tools for Prostate Cancer
2026-05-27
MDV3100 (Enzalutamide) empowers researchers to dissect androgen receptor heterogeneity and resistance in prostate cancer models with unmatched precision. This article details validated protocols, advanced use-cases, and troubleshooting strategies that maximize the compound’s impact in AR signaling and apoptosis studies.
Deep Learning Unmasks Cardiotoxicity in iPSC-CM Screening
2026-05-26
Grafton et al. (2021) present a scalable deep learning-based platform using iPSC-derived cardiomyocytes to phenotype and quantify drug-induced cardiotoxicity. This approach enables early detection of cardiac liabilities, offering a robust tool for translational researchers aiming to de-risk drug discovery.
THZ1: Covalent CDK7 Inhibitor Transforming T-ALL Research
2026-05-26
THZ1, a covalent CDK7 inhibitor from APExBIO, offers unrivaled selectivity and potency for transcription regulation studies in cancer biology, especially T-ALL. This guide delivers actionable workflows, troubleshooting insights, and highlights the unique resistance-overcoming features validated by recent mechanistic research.
Perifosine (KRX-0401): Mechanistic Insights in Cancer Apopto
2026-05-26
Discover how Perifosine (KRX-0401) uniquely induces apoptosis through Akt pathway inhibition, with advanced mechanistic analysis and protocol guidance for cancer research. This article offers a deeper perspective on apoptosis assays and the caspase activation pathway.
IRG1-Itaconic Acid Axis Restrains TBK1-Driven Type I IFN Res
2026-05-25
Chai et al. (2025) elucidate how the IRG1-generated metabolite itaconic acid directly alkylates TBK1, disrupting its activation and providing negative feedback on type I interferon signaling. This mechanistic insight advances understanding of metabolic-immunological crosstalk and supports development of selective pathway inhibitors for diseases linked to hyperinflammation.
Adipose-Neural Axis in Epicardial Fat-Linked Cardiac Arrhyth
2026-05-24
Fan et al. (2024) present direct evidence that the adipose-neural axis, mediated through leptin and neuropeptide Y signaling, plays a pivotal role in epicardial adipose tissue (EAT)-related cardiac arrhythmias. Their coculture model reveals mechanistic pathways and therapeutic targets relevant to arrhythmogenesis in atrial fibrillation.
Mitochondrial-Linked Apoptosis and Muscle Atrophy in Ovarian
2026-05-23
This study interrogates whether mitochondrial ROS-triggered apoptosis or necroptosis drive skeletal muscle atrophy during ovarian cancer progression in mice. Using the mitochondrial-targeted antioxidant SkQ1, the authors reveal that inhibiting mitochondrial apoptosis does not prevent muscle loss, challenging assumptions about cell death pathways in cancer cachexia.
RESTRICT-seq Unveils KAT6A-Dependent Epigenetic Resistance i
2026-05-22
The reference study introduces RESTRICT-seq, a time-gated CRISPR screening method that uncovers new epigenetic dependencies underlying resistance in squamous cell carcinoma (SCC). By functionally dissecting KAT6A’s role in oncogene-induced senescence and therapeutic response, the work provides actionable insights for precision epigenetic research.
461 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page